Back

An estimate of pediatric lives saved due to non-pharmacologic interventions during the early COVID-19 pandemic

Faust, J. S.; Renton, B.; Du, C.; Chen, A. J.; Li, S.-X.; Lin, Z.; Krumholz, H. M.

2023-04-20 public and global health
10.1101/2023.04.18.23288763
Show abstract

The net effect of the pandemic mitigation strategies on childhood mortality is not known. During the first year of the COVID-19 pandemic, mitigation policies and behaviors were widespread, and although vaccinations and effective treatments were not yet widely available, the risk of death from SARS-CoV-2 infection was low. In that first year, there was a 7% decrease in medical ("natural causes") mortality among children ages 0-9 during the first pandemic year (5% among infants <1 year and 15% among children ages 1-9) in the United States, resulting in an estimated 1,488 deaths due to medical causes averted among children ages 0-9, and 1,938 deaths averted over 24 months. The usual expected surge in winter medical deaths, particularly among children ages >1 year was absent. However, smaller increases in external ("non-natural causes") mortality were also observed during the study period, which decreased the overall number of pediatric deaths averted during both years and the pandemic period. In total, 1,468 fewer all-cause pediatric deaths than expected occurred in the United States during the first 24 months of the COVID-19 pandemic.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
JAMA Network Open
based on 125 papers
Top 0.4%
13.0%
2
PLOS ONE
based on 1737 papers
Top 44%
11.5%
3
Clinical Infectious Diseases
based on 219 papers
Top 5%
5.4%
4
JAMA Pediatrics
based on 10 papers
Top 0.1%
5.4%
5
Pediatrics
based on 10 papers
Top 0.2%
4.6%
6
Vaccine
based on 140 papers
Top 2%
3.0%
7
The Journal of Pediatrics
based on 15 papers
Top 0.5%
3.0%
8
Frontiers in Public Health
based on 135 papers
Top 10%
2.9%
9
Scientific Reports
based on 701 papers
Top 54%
2.9%
50% of probability mass above
10
BMC Public Health
based on 148 papers
Top 10%
2.5%
11
Pediatric Infectious Disease Journal
based on 16 papers
Top 0.8%
2.5%
12
Nature Communications
based on 483 papers
Top 26%
2.4%
13
Public Health
based on 34 papers
Top 2%
1.9%
14
The Lancet Regional Health - Americas
based on 20 papers
Top 0.2%
1.9%
15
eClinicalMedicine
based on 55 papers
Top 2%
1.4%
16
BMJ Open
based on 553 papers
Top 46%
1.3%
17
PLOS Medicine
based on 95 papers
Top 12%
1.2%
18
BMC Medicine
based on 155 papers
Top 17%
1.2%
19
Vaccine: X
based on 16 papers
Top 1%
0.9%
20
JAMA
based on 17 papers
Top 1%
0.8%
21
BMC Infectious Diseases
based on 110 papers
Top 17%
0.8%
22
The Journal of Infectious Diseases
based on 137 papers
Top 10%
0.8%
23
Vaccines
based on 131 papers
Top 6%
0.8%
24
BMJ Paediatrics Open
based on 20 papers
Top 2%
0.8%
25
International Journal of Infectious Diseases
based on 115 papers
Top 20%
0.7%
26
PLOS Global Public Health
based on 287 papers
Top 22%
0.7%
27
Nature Medicine
based on 88 papers
Top 18%
0.7%